SpecGx

The generic/API portion of Mallinckrodt will become "SpecGx LLC" by summer. Only the branded side will carry the name Mallinckrodt. Kinda of funny given the fact that all the brands are acquired products.

"Growing the Generics business" line was a complete joke. Projects havent gone anywhere. Not even money to pay for clinical studies. Massive layoffs today. No generic pipeline so guess no need for R&D.

This company is a disaster for both brands and speciality generics. The people running this clown show...

 

and they're bailing on in house generics as evidenced by the gutting of r&d. Guess spec pipeline will be strictly bdl going forward.

what a dumpster fire.

 

Well,that means it will be sold by Sept!!!! Gotta keep wall street spinning with BS because reality is. Ot what they want to hear.

 

The "executives" should have focused on making their generics businesses more lean three years ago, and that includes the business sold to Geurbet. Instead, they invested in brands, because they are greedy. Now, their chickens are coming home to roost.

 

This explains why my methadone is so weak these past few months. Not cool!!!

 

Just noticed my Methadone switched to SpecGX LLC. I have been wondering why it hadn't been working like in the past. Now I know why. What a joke

 

How long has it been switched to a new company? I’ve been noticing my once stable dose has not been working for months

 

No one’s going to buy this pig! Read the news the latest suitors bailed on the deal. Stock heading to single digits with the announcement of another quarter with massive losses!

 

Heard they are planning to sell individual assets now..

 

Time to put some lipstick on the pig and try to dress it up

 

Anybody heard anything recent on Generics sale?

 

Yes, no one wants it

 

It's made in the same place, same materials, same people. Only the name on the label changed.

 

abd the price you forgot..... asshole

 

It seems there IS someone interested in Generics!

 

Is Aurobindo still the only possible buyer? Or has anyone else been rumored to step up?

 

Intas will have to change tactics with Aurobindo stepping back in.

 

Didn’t think Intas was interested in pursuing SpecGX again. Sounds like it’s Aurobindo or bust.

 

Clock’s ticking on a SpecGX sale. Pretty soon the FY19 budgets will be drawn up and the division will revert back to continued operations if there’s no sale. How much you wanna bet MNK gets stuck with the Generics division at the end of 2018?